Short Interest in Biotricity, Inc. (NASDAQ:BTCY) Decreases By 18.7%

Biotricity, Inc. (NASDAQ:BTCY) saw a large decrease in short interest in the month of June. As of June 15th, there was short interest totalling 503,000 shares, a decrease of 18.7% from the May 31st total of 618,400 shares. Currently, 5.0% of the company’s shares are short sold. Based on an average daily trading volume, of 76,700 shares, the short-interest ratio is presently 6.6 days.

Biotricity Stock Down 11.2 %

BTCY traded down $0.10 during trading on Monday, reaching $0.80. The company had a trading volume of 55,202 shares, compared to its average volume of 75,620. The business has a 50 day simple moving average of $1.10 and a 200-day simple moving average of $1.12. The stock has a market cap of $7.53 million, a P/E ratio of -0.61 and a beta of 1.40. Biotricity has a 52 week low of $0.70 and a 52 week high of $3.78.

Biotricity (NASDAQ:BTCY) last released its quarterly earnings results on Thursday, June 27th. The company reported ($0.47) EPS for the quarter, missing analysts’ consensus estimates of ($0.36) by ($0.11). The company had revenue of $3.18 million for the quarter, compared to analysts’ expectations of $3.20 million. As a group, equities research analysts expect that Biotricity will post -0.43 EPS for the current fiscal year.

Institutional Investors Weigh In On Biotricity

A hedge fund recently bought a new stake in Biotricity stock. Advisor Resource Council acquired a new stake in Biotricity, Inc. (NASDAQ:BTCY) during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 79,070 shares of the company’s stock, valued at approximately $117,000. Advisor Resource Council owned about 0.84% of Biotricity as of its most recent SEC filing. Institutional investors and hedge funds own 3.89% of the company’s stock.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.